oleclumab
conatumumab
panitumumab
mapatumumab
drozitumab
patritumab
duligotuzumab
inotuzumab
naptumomab estafenatox
onartuzumab
dacetuzumab
matuzumab
lintuzumab
lexatumumab
tenatumomab
tigatuzumab
inotuzumab ozogamicin
dalotuzumab
figitumumab
nofetumomab
pamrevlumab
sibrotuzumab
acrixolimab
adecatumumab
lucatumumab
avelumab
iratumumab
pritumumab
teprotumumab
durvalumab
cixutumumab
apolizumab
volociximab
ramucirumab
cergutuzumab
agonistic monoclonal antibody
ocrelizumab
carlumab
cantuzumab
tucotuzumab
elotuzumab
samalizumab
sonepcizumab
ipilimumab
glembatumumab
intetumumab
oportuzumab monatox
alacizumab
bivatuzumab
brolucizumab